| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $689.1M | +11.5% |
| Cost of Revenue | $170.4M | +6.3% |
| Gross Profit | $518.7M | +13.3% |
| R&D Expense | $177.4M | +14.8% |
| SG&A Expense | $118.9M | -4.1% |
| Operating Income | -$11.3M | +87.8% |
| Pre-tax Income | $48.9M | +154.7% |
| Income Tax | $2.0M | +271.3% |
| Net Income | $46.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.6M | -38.4% |
| Short-term Investments | $470.5M | -15.6% |
| Accounts Receivable | $103.1M | +58.8% |
| Current Assets | $883.4M | -5.1% |
| Total Assets | $1.04B | -4.0% |
| Current Liabilities | $293.0M | +18.3% |
| Long-term Debt | $356.1M | -36.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.2M | +315.0% |
| Capital Expenditures | $692K | -44.6% |
| Investing Cash Flow | $88.3M | +227.1% |
| Financing Cash Flow | -$114.3M | -1979.4% |
| Free Cash Flow | $26.5M | +399.5% |
| +152.2% |
| EPS (Basic) | $0.35 | +150.7% |
| EPS (Diluted) | $0.06 | +108.7% |
| Total Liabilities |
| $656.5M |
| -21.0% |
| Stockholders' Equity | $381.1M | +53.1% |